Compare
5 stocks, side by sideRelative performance · rebased to 100
RXRXTSHACAPRSNDXZYME
| RXRXRecursion Pharmaceuticals, Inc. | TSHATaysha Gene Therapies, Inc. | CAPRCapricor Therapeutics, Inc. | SNDXSyndax Pharmaceuticals, Inc. | ZYMEZymeworks Inc. | |
|---|---|---|---|---|---|
| Smart Score | 3/10 | 5/10 | 5/10 | 5/10 | 3/10 |
| Price | $3.34 | $6.21 | $30.40 | $19.81 | $23.77 |
| 1 month | +12% | +11% | +3.5% | -0.45% | -6.4% |
| 1 year | -36% | +162% | +229% | +115% | +85% |
| 5 year | -90% | -75% | +501% | +1.2% | -38% |
| P/E (TTM) | -3.1 | -13.7 | -15.4 | -7.2 | -16.9 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $1.8B | $1.8B | $1.8B | $1.8B | $1.7B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.